Protein Glycation by Glyoxal Promotes Amyloid Formation by Islet Amyloid Polypeptide.

Protein glycation, also known as nonenzymatic glycosylation, is a spontaneous post-translational modification that would change the structure and stability of proteins or hormone peptides. Recent studies have indicated that glycation plays a role in type 2 diabetes (T2D) and neurodegenerative diseases. Over the last two decades, many types of advanced glycation end products (AGEs), formed through the reactions of an amino group of proteins with reducing sugars, have been identified and detected in vivo. However, the effect of glycation on protein aggregation has not been fully investigated. In this study, we aim to elucidate the impact of protein glycation on islet amyloid polypeptide (IAPP, also known as amylin) aggregation, which was strongly associated with T2D. We chemically synthesized glycated IAPP (AGE-IAPP) to mimic the consequence of this hormone peptide in a hyperglycemia (high blood sugar) environment. Our data revealed that AGE-IAPP formed amyloid faster than normal IAPP, and higher-molecular-weight AGE-IAPP oligomers were also observed in the early stage of aggregation. Circular dichroism spectra also indicated that AGE-IAPP exhibited faster conformational changes from random coil to its β-sheet fibrillar states. Moreover, AGE-IAPP can induce normal IAPP to expedite its aggregation process, and its fibrils can also act as templates to promote IAPP aggregation. AGE-IAPP, like normal IAPP, is capable of interacting with synthetic membranes and also exhibits cytotoxicity. Our studies demonstrated that glycation modification of IAPP promotes the amyloidogenic properties of IAPP, and it may play a role in accumulating additional amyloid during T2D progression.

[1]  Peter Marek,et al.  Deamidation accelerates amyloid formation and alters amylin fiber structure. , 2012, Journal of the American Chemical Society.

[2]  Norbert Opitz,et al.  Interaction of hIAPP with Model Raft Membranes and Pancreatic β‐Cells: Cytotoxicity of hIAPP Oligomers , 2010, Chembiochem : a European journal of chemical biology.

[3]  D. Raleigh,et al.  Islet amyloid polypeptide toxicity and membrane interactions , 2013, Proceedings of the National Academy of Sciences.

[4]  A. Coelho,et al.  Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation , 2011, BMC Biochemistry.

[5]  L. Altucci,et al.  D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts. , 2016, Biochimica et biophysica acta.

[6]  Nirmal Singh,et al.  Advanced Glycation End Products and Diabetic Complications , 2014, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[7]  D. Longnecker,et al.  The relation of islet amyloid to the clinical type of diabetes. , 1981, Human pathology.

[8]  S. Bourgault,et al.  Role of Site-Specific Asparagine Deamidation in Islet Amyloid Polypeptide Amyloidogenesis: Key Contributions of Residues 14 and 21. , 2017, Biochemistry.

[9]  D. Raleigh,et al.  A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides. , 2009, Protein engineering, design & selection : PEDS.

[10]  Joan-Emma Shea,et al.  The amyloid formation mechanism in human IAPP: dimers have β-strand monomer-monomer interfaces. , 2011, Journal of the American Chemical Society.

[11]  Selective serotonin reuptake inhibitor, fluoxetine, impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells , 2017, Scientific Reports.

[12]  A. V. van Kessel,et al.  Islet amyloid polypeptide: Identification and chromosomal localization of the human gene , 1988, FEBS letters.

[13]  H. Lashuel,et al.  Glycation potentiates &agr;-synuclein-associated neurodegeneration in synucleinopathies , 2017, Brain : a journal of neurology.

[14]  Paul J Thornalley,et al.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.

[15]  Xiaorong Zhu,et al.  Role of β-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide , 2004 .

[16]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Walter,et al.  Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease , 2011, Aging.

[18]  D. Raleigh,et al.  Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide. , 2005, Organic letters.

[19]  D. Raleigh,et al.  Role of aromatic interactions in amyloid formation by islet amyloid polypeptide. , 2013, Biochemistry.

[20]  Andrew D. Miranker,et al.  Direct detection of transient α‐helical states in islet amyloid polypeptide , 2007 .

[21]  P. Butler,et al.  β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few? , 2013, Diabetes.

[22]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Raleigh,et al.  Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? , 2006, Journal of molecular biology.

[24]  C. Delgado-Andrade.  Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation. , 2016, Food & function.

[25]  D. Raleigh,et al.  Mutational analysis of preamyloid intermediates: the role of his-tyr interactions in islet amyloid formation. , 2014, Biophysical journal.

[26]  Ayyalusamy Ramamoorthy,et al.  Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. , 2011, Biochimica et biophysica acta.

[27]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[28]  Nessar Ahmed,et al.  Advanced glycation endproducts--role in pathology of diabetic complications. , 2005, Diabetes research and clinical practice.

[29]  David Eisenberg,et al.  Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process , 2009, Protein science : a publication of the Protein Society.

[30]  G. Irace,et al.  Differential effects of glycation on protein aggregation and amyloid formation , 2014, Front. Mol. Biosci..

[31]  D. Raleigh,et al.  Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects. , 2012, Biochemistry.

[32]  G. Bitan,et al.  Molecular tweezers inhibit islet amyloid polypeptide assembly and toxicity by a new mechanism. , 2015, ACS chemical biology.

[33]  C. Dobson,et al.  Observation of sequence specificity in the seeding of protein amyloid fibrils , 2004, Protein science : a publication of the Protein Society.

[34]  A. Miranker,et al.  Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. , 2008, Protein engineering, design & selection : PEDS.

[35]  Ralf Langen,et al.  Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. , 2006, American journal of physiology. Endocrinology and metabolism.

[36]  D. Raleigh,et al.  The role of His-18 in amyloid formation by human islet amyloid polypeptide. , 2005, Biochemistry.

[37]  D. Raleigh,et al.  A Free Energy Barrier Caused by the Refolding of an Oligomeric Intermediate Controls the Lag Time of Amyloid Formation by hIAPP. , 2017, Journal of the American Chemical Society.

[38]  Neelanjana Sengupta,et al.  Glycation induces conformational changes in the amyloid-β peptide and enhances its aggregation propensity: molecular insights. , 2016, Physical chemistry chemical physics : PCCP.

[39]  Ronald Wetzel,et al.  Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils* , 2004, Journal of Biological Chemistry.

[40]  Frank Wien,et al.  BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra , 2018, Nucleic Acids Res..

[41]  Maarten F. M. Engel,et al.  Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in β-Cell Death in Type 2 Diabetes Mellitus , 2008, Experimental diabetes research.

[42]  H. Qing,et al.  Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property. , 2016, Biochimica et biophysica acta.

[43]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[44]  A. Cerami,et al.  Protein glycation, diabetes, and aging. , 2001, Recent progress in hormone research.

[45]  D. Raleigh,et al.  Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition. , 2017, Biochemistry.

[46]  J. Bernhagen,et al.  Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide. , 1998, European journal of biochemistry.

[47]  T. Ban,et al.  Direct Observation of Amyloid Fibril Growth Monitored by Thioflavin T Fluorescence* 210 , 2003, The Journal of Biological Chemistry.

[48]  J. Finnerty,et al.  The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. , 2001, Diabetes.

[49]  P. Westermark,et al.  Quantitative studies on amyloid in the islets of Langerhans. , 1972, Upsala journal of medical sciences.

[50]  Peter Marek,et al.  Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity , 2012, FEBS letters.

[51]  G. Soukhatcheva,et al.  Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells. , 2005, Endocrinology.

[52]  R. L. Hull,et al.  Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? , 2010, Diabetologia.

[53]  D. Raleigh,et al.  RAGE binds preamyloid IAPP intermediates and mediates pancreatic &bgr; cell proteotoxicity , 2018, The Journal of clinical investigation.

[54]  P. Riederer,et al.  Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. , 1997, Biochimica et biophysica acta.

[55]  D. Harrison,et al.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.

[56]  P. Westermark,et al.  Amyloid in Human Islets of Langerhans: Immunologic Evidence That Islet Amyloid Polypeptide Is Modified in Amyloidogenesis , 2000, Pancreas.

[57]  Xiang-Shu Cheng,et al.  Glycation exacerbates the neuronal toxicity of β-amyloid , 2013, Cell Death and Disease.